Publications en collaboration avec des chercheurs de Medical University of Vienna (11)

2023

  1. Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” [J Hepatol 79(4) (2023 Oct) 967–976] (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022))

    Journal of Hepatology

  2. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis

    Journal of Hepatology, Vol. 79, Núm. 4, pp. 967-976

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

  2. Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets

    Molecular Oncology, Vol. 15, Núm. 2, pp. 364-380

2020

  1. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

  2. Proceedings of the 4thBEAT-PCD Conference and 5thPCD Training School

    BMC Proceedings, Vol. 14

2018

  1. Genomic amplifications and distal 6q loss: Novel markers for poor survival in high-risk neuroblastoma patients

    Journal of the National Cancer Institute, Vol. 110, Núm. 10

  2. Heterogeneous MYCN amplification in neuroblastoma: A SIOP Europe Neuroblastoma Study

    British Journal of Cancer, Vol. 118, Núm. 11, pp. 1502-1512

2017

  1. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice

    Gastroenterology, Vol. 153, Núm. 4, pp. 924-935

2016

  1. The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma

    International Journal of Cancer, Vol. 139, Núm. 1, pp. 153-163

2013

  1. Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

    Pediatric Blood and Cancer, Vol. 60, Núm. 3, pp. 363-370